MedPath

Imperial College London

Imperial College London logo
πŸ‡§πŸ‡ͺBelgium
Ownership
Private
Established
1907-07-08
Employees
5K
Market Cap
-
Website
http://www.imperial.ac.uk

Markers for Chronic Obstructive Pulmonary Disease (COPD)

Withdrawn
Conditions
Healthy Non-smokers
Current Smokers
COPD Patients
First Posted Date
2005-09-16
Last Posted Date
2019-07-05
Lead Sponsor
Imperial College London
Registration Number
NCT00180622
Locations
πŸ‡¬πŸ‡§

Section of Airway Disease, Asthma Lab, Imperial College London, Royal Brompton Hospital, London, United Kingdom

Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages

Completed
Conditions
Recurrent Miscarriages
First Posted Date
2005-09-16
Last Posted Date
2023-10-16
Lead Sponsor
Imperial College London
Target Recruit Count
400
Registration Number
NCT00180804
Locations
πŸ‡¬πŸ‡§

St. Mary's Hospital, London, United Kingdom

Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss

Phase 1
Withdrawn
Conditions
Antiphospholipid Syndrome
First Posted Date
2005-09-16
Last Posted Date
2024-02-26
Lead Sponsor
Imperial College London
Registration Number
NCT00180778
Locations
πŸ‡¬πŸ‡§

St. Mary's Hospital, London, United Kingdom

Inflammation and Corticosteroid Responsiveness in Severe Asthma

Completed
Conditions
Asthma
First Posted Date
2005-09-16
Last Posted Date
2019-10-04
Lead Sponsor
Imperial College London
Target Recruit Count
39
Registration Number
NCT00180661
Locations
πŸ‡¬πŸ‡§

Royal Brompton Hospital, London, United Kingdom

Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.

Completed
Conditions
Antiphospholipid Syndrome
First Posted Date
2005-09-16
Last Posted Date
2022-08-08
Lead Sponsor
Imperial College London
Target Recruit Count
250
Registration Number
NCT00180817
Locations
πŸ‡¬πŸ‡§

St. Mary's Hospital, London, United Kingdom

Clinical Trial of the Use of Intraperitoneal Local Anaesthetic

Phase 3
Completed
Conditions
Pain, Postoperative
Interventions
Drug: Normal Saline
Other: No Intraperitoneal Therapeutics
Drug: Injected Bupivacaine intraperitoneally
Drug: Nebulised Bupivacaine intraperitoneally
First Posted Date
2005-09-16
Last Posted Date
2015-09-15
Lead Sponsor
Imperial College London
Target Recruit Count
80
Registration Number
NCT00180687
Locations
πŸ‡¬πŸ‡§

St. Mary's Hospital, London, United Kingdom

Molecular Mechanism of Asthma

Not Applicable
Withdrawn
Conditions
Asthma
First Posted Date
2005-09-16
Last Posted Date
2019-05-09
Lead Sponsor
Imperial College London
Registration Number
NCT00180726
Locations
πŸ‡¬πŸ‡§

Airway Disease, NHLI, Imperial College, London, United Kingdom

Nitric Oxide (NO) Donors and Inhibitors Study: Study to Evaluate L-Arginine and Aminoguanidine in Asthmatic Subjects

Not Applicable
Completed
Conditions
Asthma
Interventions
Drug: Placebos
First Posted Date
2005-09-12
Last Posted Date
2019-07-10
Lead Sponsor
Imperial College London
Target Recruit Count
16
Registration Number
NCT00159380
Locations
πŸ‡¬πŸ‡§

Section of Airway Disease, Asthma Lab, Imperial College London, Royal Brompton Hospital, London, United Kingdom

Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control

Withdrawn
Conditions
Healthy Non-smokers
Healthy Smokers
Patients With Mild Asthma
Patints With COPD (GOLD II)
First Posted Date
2005-09-12
Last Posted Date
2019-07-10
Lead Sponsor
Imperial College London
Registration Number
NCT00159302
Locations
πŸ‡¬πŸ‡§

Section of Airway Disease, Asthma Lab, Imperial College London, Royal Brompton Hospital, London, United Kingdom

Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy

Phase 1
Completed
Conditions
Duchenne Muscular Dystrophy
Interventions
Drug: AVI-4658 (PMO)
First Posted Date
2005-09-12
Last Posted Date
2019-12-05
Lead Sponsor
Imperial College London
Target Recruit Count
7
Registration Number
NCT00159250
Locations
πŸ‡¬πŸ‡§

Dubowitz Neuromuscular Centre, Hammersmith Hospital and Clinical Trails Unit, St Mary's Hospital, London, United Kingdom

Β© Copyright 2025. All Rights Reserved by MedPath